Sudogest | Chlorpheniramine Maleate, Pseudoephedrine Hcl Tablet while Breastfeeding
American Academy of Pediatrics and other medical experts exclusively recommend to breastfeed the baby for first 6 months. Once you introduce baby to other foods it is recommended to breastfeed for at least first year of babys life. Taking medication while breastfeeding could be tricky as most drugs pass in breast milk. In this article we will evaluate Sudogest | Chlorpheniramine Maleate, Pseudoephedrine Hcl Tablet for its safety in breastfeeding.

What is Sudogest | Chlorpheniramine Maleate, Pseudoephedrine Hcl Tablet used for?


temporarily relieves these symptoms due to hay fever (allergic rhinitis) or other upper respiratory allergies: runny nose itchy, watery eyes nasal congestion sneezing itching of the nose or throat temporarily relieves these symptoms due to the common cold: runny nose sneezing sinus congestion and pressure

Brief: Antihistamine Nasal decongestant

Can I continue breastfeeding if I am using Sudogest | Chlorpheniramine Maleate, Pseudoephedrine Hcl Tablet? How long does it stays in breast milk?

Sudogest | Chlorpheniramine Maleate, Pseudoephedrine Hcl Tablet low risk for breastfeeding
Chlorpheniramine maleate and Pseudoephedrine hydrochloride are the two main ingredients of Sudogest | Chlorpheniramine Maleate, Pseudoephedrine Hcl Tablet. Based on our individual analysis of Chlorpheniramine maleate and Pseudoephedrine hydrochloride we can safely say that Sudogest | Chlorpheniramine Maleate, Pseudoephedrine Hcl Tablet has low risk while breastfeeding. Below we have summarized the usage of Chlorpheniramine maleate and Pseudoephedrine hydrochloride while breastfeeding, we recommend you to go through it for better understanding of your usage.

Sudogest | Chlorpheniramine Maleate, Pseudoephedrine Hcl Tablet Breastfeeding Analsys


Chlorpheniramine maleate while Breastfeeding

Low Risk

CAS Number: 132-22-9

First generation antihistaminic and alchylamine drug, with sedative effect. Its active isomer is Dexchlorfeniramine. Likely inhibition of lactation within the first weeks post delivery because anti-prolactin effect.. Short-term and low dose (2 mg one or twice-day) treatment is compatible with breastfeeding. Be aware of somnolence in the child. For long-term treatment an alternative drug should be preferred. Compounds in association with expectorants, corticoids and cough relief medicines are available. Avoid drug associations especially while breastfeeding. Follow-up for sedation and feeding ability of the infant. Bed-sharing is not recommended for mothers who are taking this medication.

Pseudoephedrine hydrochloride while Breastfeeding

Low Risk

CAS Number: 90-82-4

Marketed on multiple compounds as a constituent of antitussives, mucolytics, expectorants and nasal decongestants (Nice 2000).Simple formulations (one active ingredient per drug) are preferable even more while breastfeeding. It is excreted into breast milk in a clinically non-significant amount (Findlay 1984, Kanfer 1993, Nice 2000, Aljazaf 2003) without major problems having been reported in infants whose mothers had received this medication (Ito 1993, Aljazaf 2003, Soasan 2014). Two infants out of ten appeared with mild irritability that did not require medical care (Ito 1993) with only 4 cases related to maternal pseudoephedrine intake having been declared to the French Pharmaceutical Surveillance Database in 26 years (Soasan 2014) . According to one author, it may decrease the milk production, hence a high intake of fluids is recommended to the mother (Nice 2000). Pseudoephedrine produced a variable and non-significant decrease on prolactin levels along with a variable decrease (between 3% and 59%, on average 25%, and a median 15%) on milk production in 8 women whose infants were beyond neonatal period (Aljazaf 2003).Based on the latter single work (Aljazaf 2003), it has been speculated with the use of pseudoephedrine to treat hypergalactia, galactorrhea and to inhibit milk production (Eglash 2014, Trimeloni 2016). Nor-pseudoephedrine was found in the urine of infants whose mothers had consumed a stimulant plant called Catha edulis o cat (Kristiansson 1987). Although not recommended during lactation by some authors (Rubin 1986, Amir 2011), others think it is compatible (Findlay 1984, Ghaeli 1993, Ito 1993, Mitchell 1999, Nice 2000). The American Academy of Pediatrics considers it to be a medication usually compatible with breastfeeding (AAP 2001). It is suggested the use of a lowest effective dose as possible avoiding a long-term use. Monitor milk production, especially if associated with use of Triprolidine (see specific info) during the neonatal period.


Sudogest | Chlorpheniramine Maleate, Pseudoephedrine Hcl Tablet Breastfeeding Analsys - 2


Chlorpheniramine maleate while Breastfeeding

CAS Number: 132-22-9

Small (2 to 4 mg), occasional doses of chlorpheniramine are acceptable during breastfeeding. Larger doses or more prolonged use might cause effects in the infant or decrease the milk supply, particularly in combination with a sympathomimetic such as spseudoephedrine or before lactation is well established. Single bedtime doses after the last feeding of the day may be adequate for many women and will minimize any effects of the drug. The nonsedating antihistamines are preferred alternatives, though.

Pseudoephedrine hydrochloride while Breastfeeding

CAS Number: 90-82-4

Although the small amounts of pseudoephedrine in breastmilk are unlikely to harm the nursing infant, it may cause irritability occasionally. A single dose of pseudoephedrine decreases milk production acutely and repeated use seems to interfere with lactation. Mothers with newborns whose lactation is not yet well established or in mothers who are having difficulties producing sufficient milk should not receive pseudoephedrine. A treatment scheme has been reported for mothers with hypergalactia that uses pseudoephedrine to decrease milk supply.[1]



I already used Sudogest | Chlorpheniramine Maleate, Pseudoephedrine Hcl Tablet and meanwhile I breastfed my baby should I be concerned?

During whole lactation period you shall first discuss with your doctor and then together you shall decide whether you shall take that drug or not however if you have already taken Sudogest | Chlorpheniramine Maleate, Pseudoephedrine Hcl Tablet then you shall inform your doctor, But you should not be worried too much as Sudogest | Chlorpheniramine Maleate, Pseudoephedrine Hcl Tablet comes in category of low risk drug.


My doctor has prescribed me Sudogest | Chlorpheniramine Maleate, Pseudoephedrine Hcl Tablet, what should I do?

Though Sudogest | Chlorpheniramine Maleate, Pseudoephedrine Hcl Tablet dose not comes in category of safe drugs rather it comes in category of low risk but if your doctor is aware that you are breastfeeding your baby and has still recommended it then its advantages must be outweighing the risks.


If I am using Sudogest | Chlorpheniramine Maleate, Pseudoephedrine Hcl Tablet, will my baby need extra monitoring?

Not much


Who can I talk to if I have questions about usage of Sudogest | Chlorpheniramine Maleate, Pseudoephedrine Hcl Tablet in breastfeeding?

US
National Womens Health and Breastfeeding Helpline: 800-994-9662 (TDD 888-220-5446) 9 a.m. and 6 p.m. ET, Monday through Friday

UK
National Breastfeeding Helpline: 0300-100-0212 9.30am to 9.30pm, daily
Association of Breastfeeding Mothers: 0300-330-5453
La Leche League: 0345-120-2918
The Breastfeeding Network supporter line in Bengali and Sylheti: 0300-456-2421
National Childbirth Trust (NCT): 0300-330-0700

Australia
National Breastfeeding Helpline: 1800-686-268 24 hours a day, 7 days a week

Canada
Telehealth Ontario for breastfeeding: 1-866-797-0000 24 hours a day, 7 days a week

Drug Brands with same Active ingredients